INDO US BIOTECH
Back to Balance Sheet
|
INDO US BIOTECH Last 5 Year Total Current Liabilities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Current Liabilities | ₹17 Cr | ₹12 Cr | ₹12 Cr | ₹18 Cr | ₹17 Cr |
What is the latest Total Current Liabilities ratio of INDO US BIOTECH ?
Year | Total Current Liabilities |
---|---|
Mar2024 | ₹17 Cr |
Mar2023 | ₹12 Cr |
Mar2022 | ₹12 Cr |
Mar2021 | ₹18 Cr |
Mar2020 | ₹17 Cr |
How is Total Current Liabilities of INDO US BIOTECH Trending?
Years | Total Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹17 Cr | 42.06 | |
Mar2023 | ₹12 Cr | 0.70 | |
Mar2022 | ₹12 Cr | -32.03 | |
Mar2021 | ₹18 Cr | 7.35 | |
Mar2020 | ₹17 Cr | - |
Compare Total Current Liabilities of peers of INDO US BIOTECH
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
INDO US BIOTECH | ₹335.8 Cr | -7.1% | 7.1% | -26.5% | Stock Analytics | |
BOMBAY BURMAH TRADING CORPORATION | ₹12,930.5 Cr | -1.4% | -7.1% | -19.2% | Stock Analytics | |
KAVERI SEED COMPANY | ₹5,819.8 Cr | 3.3% | -1.9% | -3.8% | Stock Analytics | |
VENKYS (INDIA) | ₹2,007.8 Cr | -4.4% | -10.3% | -40.4% | Stock Analytics | |
BOMBAY SUPER HYBRID SEEDS | ₹1,370.4 Cr | -1.5% | -4.6% | -33.3% | Stock Analytics | |
MANGALAM GLOBAL ENTERPRISE | ₹541.1 Cr | -1% | -2.6% | NA | Stock Analytics |
INDO US BIOTECH Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
INDO US BIOTECH | -7.1% |
7.1% |
-26.5% |
SENSEX | -0% |
-2.1% |
1.1% |
You may also like the below Video Courses